Jose-Mario Capo-Chichi
6PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 22, 2025
FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells.Joana L Araújo, Elvin Wagenblast, Veronique Voisin
|Mar 06, 2024
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.Maria Agustina Perusini, Daniela Žáčková, Taehyung Kim
|Jan 03, 2024
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN.Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi
|Dec 22, 2023
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui
|Sep 04, 2023
Gastrointestinal Stromal Tumours (GISTs) with KRAS Mutation: A Rare but Important Subset of GISTs.Dorinda Mullen, Rajkumar Vajpeyi, Jose-Mario Capo-Chichi
|Mar 16, 2022
A t(6;14;9)(p22;q22;q34) three-way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia.Adam C Smith, Dawn Maze, Daniel Xia
Pageof 1
Frequent Collaborators
3 joint publications
Mark Minden
2 joint publications
Dawn Maze
2 joint publications
Sagi Abelson
1 joint publications
Adam C Smith
1 joint publications
Daniel Xia
1 joint publications
Ian King
1 joint publications
Dorinda Mullen
1 joint publications
Rajkumar Vajpeyi
1 joint publications
John E Dick
1 joint publications
Newton Wong
